Latanoprost Blumont

Latanoprost, the active ingredient in Latanoprost Blumont, is a prostaglandin analog presented as an ophthalmic solution for ocular administration. It works by increasing uveoscleral outflow of aqueous humor, thereby reducing intraocular pressure in adults diagnosed with primary open‑angle glaucoma or ocular hypertension and is commonly prescribed by ophthalmologists as a first‑line therapy.

GNH USA supplies Latanoprost Blumont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across EU and other markets.

Latanoprost is used to manage conditions that involve elevated intraocular pressure within the glaucoma disease family.

- Primary open‑angle glaucoma: reduces intraocular pressure to slow visual field loss. - Ocular hypertension: lowers pressure to prevent progression to glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): helps control pressure when other therapies are insufficient.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eyelash changes: increased length, thickness, or darkness. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe ocular inflammation: uveitis or iritis. - Allergic reaction: swelling, itching, or rash around the eye. - Paradoxical IOP increase: unexpected rise in pressure. - Corneal edema: swelling of the cornea affecting clarity. - Vision loss: rapid deterioration requiring immediate attention. - Endophthalmitis: intraocular infection, a medical emergency.

Before using Latanoprost, consider the following safety measures. - Monitor intraocular pressure: schedule regular measurements after initiation. - Assess for ocular infection: avoid use if active conjunctivitis or keratitis is present. - Avoid concurrent prostaglandin analog eye drops: risk of additive side effects. - Use with caution in patients with a history of uveitis or ocular inflammation. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Other prostaglandin analog eye drops: may increase ocular side effects. - Systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect may cause hypotony.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce Latanoprost efficacy. - Beta‑blocker eye drops: additive pressure‑lowering effect requires monitoring. - Anticholinergic agents: possible reduced ocular surface tolerance.